1

Mini-antibodies Revive tumor suppressor p53: New New Pathway for Malignant Treatment

News Discuss 
A significant discovery in cancer research is occurring with the use of VHH fragments to reactivate dysfunctional p53. This essential malignant protector protein is frequently inactivated in many types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story